Nanoparticulate adjuvants and delivery systems for allergen immunotherapy

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  De Souza Rebouças, Juliana ^a   Esparza, Irene ^a   Ferrer, Marta ^b   Sanz, María Luisa ^b   Irache, Juan Manuel ^a   Gamazo, Carlos ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALLERGEN; ALUMINUM HYDROXIDE; ARA H2; CHITOSAN; CYTOKINE; DIPHTHERIA TOXOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC AGENT; ISCOM; LEUKOTRIENE; LIPOSOME; NANOCAPSULE; NANOPARTICLE; NANOSPHERE; OLIGONUCLEOTIDE; PHOSPHORYL LIPID A; POLY(ANHYDRIDE); POLY(GAMMA GLUTAMIC ACID); POLYCAPROLACTONE; POLYESTER; POLYLACTIDE; POLYSACCHARIDE; POVIDONE; PROSTAGLANDIN; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; IMMUNOLOGICAL ADJUVANT;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC DISEASE; ALLERGIC REACTION; ANAPHYLAXIS; BIOCOMPATIBILITY; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG SOLUBILITY; EMULSION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INNATE IMMUNITY; LOCAL NASAL IMMUNOTHERAPY; NANOPARTICLE BASED ALLERGEN DELIVERY SYSTEM; NONHUMAN; PEANUT ALLERGY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; ANIMAL; DESENSITIZATION; METHODOLOGY;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES;

EID: 84858130225     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/474605     Document Type: Review

References (143)

1. Martino D. J., Prescott S. L., Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease Allergy 2010 65 1 7 15
2. Sicherer S. H., Sampson H. A., Peanut allergy: emerging concepts and approaches for an apparent epidemic Journal of Allergy and Clinical Immunology 2007 120 3 491 503 (Pubitemid 47320772)
3. Gell P. G. H., Coombs R. R. A., Clinical Aspects of Immunology 1963 1st Oxford, UK Blackwell
4. Warner J. O., Kaliner M. A., Crisci C. D., Del Giacco S., Frew A. J., Liu G. H., Maspero J., Moon H. B., Nakagawa T., Potter P. C., Rosenwasser L. J., Singh A. B., Valovirta E., Van Cauwenberge P., Henley K., Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council International Archives of Allergy and Immunology 2006 139 2 166 174 (Pubitemid 43177330)
5. Grammatikos A. P., The genetic and environmental basis of atopic diseases Annals of Medicine 2008 40 7 482 495
6. Vercelli D., Discovering susceptibility genes for asthma and allergy Nature Reviews Immunology 2008 8 3 169 182 (Pubitemid 351323288)
7. Ober C., Leavitt S. A., Tsalenko A., Howard T. D., Hoki D. M., Daniel R., Newman D. L., Wu X., Parry R., Lester L. A., Solway J., Blumenthal M., King R. A., Xu J., Meyers D. A., Bleecker E. R., Cox N. J., Variation in the interleukin 4-receptor gene confers susceptibility to asthma and atopy in ethnically diverse populations American Journal of Human Genetics 2000 66 2 517 526 (Pubitemid 30468830)
8. Hunninghake G. M., Soto-Quirs M. E., Avila L., Su J., Murphy A., Demeo D. L., Ly N. P., Liang C., Sylvia J. S., Klanderman B. J., Lange C., Raby B. A., Silverman E. K., Celedn J. C., Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood Journal of Allergy and Clinical Immunology 2007 120 1 84 90 (Pubitemid 46990504)
9. Liu X., Beaty T. H., Deindl P., Huang S. K., Lau S., Sommerfeld C., Fallin M. D., Kao W. H. L., Wahn U., Nickel R., Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study Journal of Allergy and Clinical Immunology 2004 113 3 489 495 (Pubitemid 38338955)
10. O'Mahony L., Akdis M., Crameri R., Akdis C. A., Novel immunotherapeutic approaches for allergy and asthma Autoimmunity 2010 43 7 493 503
11. Novak N., New insights into the mechanism and management of allergic diseases: atopic dermatitis Allergy 2009 64 2 265 275
12. Niederberger V., Valenta R., Molecular approaches for new vaccines against allergy Expert Review of Vaccines 2006 5 1 103 110
13. Rolland J. M., Gardner L. M., O'Hehir R. E., Allergen-related approaches to immunotherapy Pharmacology and Therapeutics 2009 121 3 273 284
14. Pauli G., Malling H. J., The current state of recombinant allergens for immunotherapy Current Opinion in Allergy and Clinical Immunology 2010 10 6 575 581
15. Strait R. T., Morris S. C., Finkelman F. D., IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc RIIb cross-linking The Journal of Clinical Investigation 2006 116 3 833 841 (Pubitemid 43326893)
16. Ma Y., Hayglass K. T., Becker A. B., Halayko A. J., Basu S., Simons F. E. R., Peng Z., Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice Allergy 2007 62 6 675 682 (Pubitemid 46763447)
17. Ma Y., HayGlass K. T., Becker A. B., Fan Y., Yang X., Basu S., Srinivasan G., Simons F. E. R., Halayko A. J., Peng Z., Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice American Journal of Respiratory and Critical Care Medicine 2007 176 5 439 445 (Pubitemid 47358097)
18. Pulsawat P., Piboonpocanun S., Sirivichayakul S., Buranapraditkun S., Jacquet A., Shimada M., Okuda K., Ruxrungtham K., Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen Journal of Investigational Allergology and Clinical Immunology 2010 20 7 582 590
19. Gupta G. K., Agrawal D. K., CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma BioDrugs 2010 24 4 225 235
20. Bernstein D. I., Epstein T., Murphy-Berendts K., Liss G. M., Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study Annals of Allergy, Asthma and Immunology 2010 104 6 530 535
21. Broos S., Lundberg K., Akagi T., Kadowaki K., Akashi M., Greiff L., Borrebaeck C. A. K., Lindstedt M., Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy Vaccine 2010 28 31 5075 5085
22. Klippstein R., Pozo D., Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies Nanomedicine 2010 6 4 523 529
23. Schll I., Boltz-Nitulescu G., Jensen-Jarolim E., Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy Journal of Controlled Release 2005 104 1 1 27 (Pubitemid 40615232)
24. Romagnani S., Immunologic influences on allergy and the TH1/TH2 balance Journal of Allergy and Clinical Immunology 2004 113 3 395 400 (Pubitemid 38338939)
25. Robinson D. S., Th-2 cytokines in allergic disease British Medical Bulletin 2000 56 4 956 968 (Pubitemid 32417162)
26. Araujo M. I., Campos R. A., Cardoso L. S., Oliveira S. C., Carvalho E. M., Immunomodulation of the allergic inflammatory response: new developments Inflammation and AllergyDrug Targets 2010 9 2 73 82
27. Zhao Y., Yang J., Gao Y.-D., Altered expressions of helper T cell (Th)1, Th2, and Th17 cytokines in CD8+ and T cells in patients with allergic asthma Journal of Asthma 2011 48 5 429 436
28. Palomares O., Yaman G., Azkur A. K., Akkoc T., Akdis M., Akdis C. A., Role of Treg in immune regulation of allergic diseases European Journal of Immunology 2010 40 5 1232 1240
29. Oboki K., Ohno T., Saito H., Nakae S., Th17 and allergy Allergology International 2008 57 2 121 134 (Pubitemid 351897666)
30. Frew A. J., Allergen immunotherapy Journal of Allergy and Clinical Immunology 2010 125 2 S306 S313
31. Valenta R., Kraft D., From allergen structure to new forms of allergen-specific immunotherapy Current Opinion in Immunology 2002 14 6 718 727 (Pubitemid 35292418)
32. Till S. J., Francis J. N., Nouri-Aria K., Durham S. R., Mechanisms of immunotherapy Journal of Allergy and Clinical Immunology 2004 113 6 1025 1034 (Pubitemid 38857978)
33. Larché M., Akdis C. A., Valenta R., Immunological mechanisms of allergen-specific immunotherapy Nature Reviews Immunology 2006 6 10 761 771 (Pubitemid 44453462)
34. Ciprandi G., Marseglia G. L., Tosca M. A., Allergen-specific immunotherapy: an update on immunological mechanisms of action Monaldi Archives for Chest Disease 2006 65 1 34 37 (Pubitemid 43676457)
35. Akdis C. A., Akdis M., Mechanisms and treatment of allergic disease in the big picture of regulatory T cells Journal of Allergy and Clinical Immunology 2009 123 4 735 746
36. Akdis M., Akdis C. A., Therapeutic manipulation of immune tolerance in allergic disease Nature Reviews Drug Discovery 2009 8 8 645 660
37. Bernstein D. I., Epstein T., Murphy-Berendts K., Liss G. M., Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study Annals of Allergy, Asthma and Immunology 2010 104 6 530 535
38. Roy S. R., Sigmon J. R., Olivier J., Moffitt J. E., Brown D. A., Marshall G. D., Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy Annals of Allergy, Asthma and Immunology 2007 99 1 82 86 (Pubitemid 47075956)
39. Canonica G. W., Passalacqua G., Noninjection routes for immunotherapy Journal of Allergy and Clinical Immunology 2003 111 3 437 448 (Pubitemid 36337857)
40. Ozdemir C., An immunological overview of allergen specific immunotherapysubcutaneous and sublingual routes Therapeutic Advances in Respiratory Disease 2009 3 5 253 262
41. Canonica G. W., Bousquet J., Casale T., Lockey R. F., Baena-Cagnani C. E., Pawankar R., Potter P. C., Bousquet P. J., Cox L. S., Durham S. R., Nelson H. S., Passalacqua G., Ryan D. P., Brozek J. L., Compalati E., Dahl R., Delgado L., Van Wijk R. G., Gower R. G., Ledford D. K., Filho N. R., Valovirta E. J., Yusuf O. M., Zuberbier T., Akhanda W., Almarales R. C., Ansotegui I., Bonifazi F., Ceuppens J., Chivato T., Dimova D., Dumitrascu D., Luigi Fontana, Katelaris C. H., Kaulsay R., Kuna P., Larenas-Linnemann D., Manoussakis M., Nekam K., Nunes C., OHehir R., MOlaguibel J., Onder N. B., Won Park J., Priftanji A., Puy R., Sarmiento L., Scadding G., Schmid-Grendelmeier P., Seberova E., Sepiashvili R., Sole D., Togias A., Tomino C., Toskala E., Van Beever H., Vieths S., Sub-lingual immunotherapy: world allergy organization position paper 2009 Allergy 2009 64 91 1 59
42. Bousquet J., Lockey R., Malling H. J., Alvarez-Cuesta E., Canonica G. W., Chapman M. D., Creticos P. J., Dayer J. M., Durham S. R., Demoly P., Goldstein R. J., Ishikawa T., Ito K., Kraft D., Lambert P. H., Lwenstein H., Mller U., Norman P. S., Reisman R. E., Valenta R., Valovirta E., Yssel H., Allergen immunotherapy: therapeutic vaccines for allergic diseasesa WHO position paper Journal of Allergy and Clinical Immunology 1998 102 4 558 562
43. Wang W., Singh M., Selection of adjuvants for enhanced vaccine potency World Journal of Vaccines 2011 1 33 78
44. Francis J. N., Durham S. R., Adjuvants for allergen immunotherapy: experimental results and clinical perspectives Current Opinion in Allergy and Clinical Immunology 2004 4 6 543 548 (Pubitemid 39573730)
45. Wheeler A. W., Woroniecki S. R., Immunological adjuvants in allergy vaccines: past, present and future Allergology International 2001 50 4 295 301 (Pubitemid 33123386)
46. Aguilar J. C., Rodrguez E. G., Vaccine adjuvants revisited Vaccine 2007 25 19 3752 3762 (Pubitemid 46589757)
47. Perrie Y., Mohammed A. R., Kirby D. J., McNeil S. E., Bramwell V. W., Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens International Journal of Pharmaceutics 2008 364 2 272 280
48. des Rieux A., Fievez V., Garinot M., Schneider Y. J., Préat V., Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach Journal of Controlled Release 2006 116 1 1 27 (Pubitemid 44792295)
49. Gupta R. K., Aluminum compounds as vaccine adjuvants Advanced Drug Delivery Reviews 1998 32 3 155 172 (Pubitemid 28267407)
50. Allison A. C., Gregoriadis G., Liposomes as immunological adjuvants Nature 1974 252 5480, article 252
51. De Becker G., Moulin V., Pajak B., Bruck C., Francotte M., Thiriart C., Urbain J., Moser M., The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells International Immunology 2000 12 6 807 815 (Pubitemid 30410453)
52. Schll I., Boltz-Nitulescu G., Jensen-Jarolim E., Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy Journal of Controlled Release 2005 104 1 1 27 (Pubitemid 40615232)
53. Tighe H., Takabayashi K., Schwartz D., Van Nest G., Tuck S., Eiden J. J., Kagey-Sobotka A., Creticos P. S., Lichtenstein L. M., Spiegelberg H. L., Raz E., Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity Journal of Allergy and Clinical Immunology 2000 106 1 124 134 (Pubitemid 30482862)
54. Tulic M. K., Fiset P. O., Christodoulopoulos P., Vaillancourt P., Desrosiers M., Lavigne F., Eiden J., Hamid Q., Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response Journal of Allergy and Clinical Immunology 2004 113 2 235 241 (Pubitemid 38210543)
55. Broos S., Lundberg K., Akagi T., Kadowaki K., Akashi M., Greiff L., Borrebaeck C. A. K., Lindstedt M., Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy Vaccine 2010 28 31 5075 5085
56. Kreuter J., Swarbrick J., Boylan J. C., Nanoparticles Encyclopaedia of Pharmaceutical Technology 1994 10 New York, NY, USA Marcel Dekker 165 190
57. Couvreur P., Barratt G., Fattal E., Legrand P., Vauthier C., Nanocapsule technology: a review Critical Reviews in Therapeutic Drug Carrier Systems 2002 19 2 99 134
58. Kumari A., Yadav S. K., Yadav S. C., Biodegradable polymeric nanoparticles based drug delivery systems Colloids and Surfaces B 2010 75 1 1 18
59. Csaba N., Garcia-Fuentes M., Alonso M. J., Nanoparticles for nasal vaccination Advanced Drug Delivery Reviews 2009 61 2 140 157
60. Madan T., Munshi N., De T. K., Maitra A., Usha Sarma P., Aggarwal S. S., Biodegradable nanoparticles as a sustained release system for the antigens/allergens of Aspergillus fumigatus: preparation and characterisation International Journal of Pharmaceutics 1997 159 2 135 147 (Pubitemid 28055849)
61. Aggarwal P., Hall J. B., McLeland C. B., Dobrovolskaia M. A., McNeil S. E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Advanced Drug Delivery Reviews 2009 61 6 428 437
62. Dobrovolskaia M. A., Aggarwal P., Hall J. B., McNeil S. E., Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Molecular Pharmaceutics 2008 5 4 487 495
63. Dobrovolskaia M. A., McNeil S. E., Immunological properties of engineered nanomaterials Nature Nanotechnology 2007 2 8 469 478 (Pubitemid 47220069)
64. Kalkanidis M., Pietersz G. A., Xiang S. D., Mottram P. L., Crimeen-Irwin B., Ardipradja K., Plebanski M., Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity Methods 2006 40 1 20 29 (Pubitemid 44415495)
65. Gautier J. C., Grangier J. L., Barbier A., Dupont P., Dussossoy D., Pastor G., Couvreur P., Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF) Journal of Controlled Release 1992 20 1 67 77
66. Couvreur P., Guiot P., Couvreur P., Biodegradable polymeric nanoparticles as drug carrier for antitumor agents Polymeric Nanoparticles and Microspheres 1986 Boca Raton, Fla, USA CRC Press 27 93
67. Bramwell V. W., Perrie Y., Particulate delivery systems for vaccines: what can we expect? Journal of Pharmacy and Pharmacology 2006 58 6 717 728 (Pubitemid 43836159)
68. Irache J. M., Esparza I., Gamazo C., Ageros M., Espuelas S., Nanomedicine: novel approaches in human and veterinary therapeutics Veterinary Parasitology 2011 180 1-2 47 71
69. Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E., Biodegradable polymeric nanoparticles as drug delivery devices Journal of Controlled Release 2001 70 1-2 1 20 (Pubitemid 32144788)
70. Peek L. J., Middaugh C. R., Berkland C., Nanotechnology in vaccine delivery Advanced Drug Delivery Reviews 2008 60 8 915 928
71. Mundargi R. C., Babu V. R., Rangaswamy V., Patel P., Aminabhavi T. M., Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide- co -glycolide) and its derivatives Journal of Controlled Release 2008 125 3 193 209
72. Tamber H., Johansen P., Merkle H. P., Gander B., Formulation aspects of biodegradable polymeric microspheres for antigen delivery Advanced Drug Delivery Reviews 2005 57 3 357 376 (Pubitemid 39555502)
73. Coombes A. G. A., Lavelle E. C., Jenkins P. G., Davis S. S., Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen Vaccine 1996 14 15 1429 1438 (Pubitemid 27008258)
74. Spiers I. D., Eyles J. E., Baillie L. W. J., Williamson E. D., Alpar H. O., Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes Journal of Pharmacy and Pharmacology 2000 52 10 1195 1201
75. Igartua M., Hernndez R. M., Esquisabel A., Gascn A. R., Calvo M. B., Pedraz J. L., Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres Journal of Controlled Release 1998 56 13 63 73 (Pubitemid 28511127)
76. Eldrige J. H., Staas J. K., Meulbroek J. A., McGhee J. R., Tice T. R., Gilley R. M., Biodegradable microspheres as a vaccine delivery system Molecular Immunology 1991 28 3 287 294
77. Combadire B., Mahé B., Particle-based vaccines for transcutaneous vaccination Comparative Immunology, Microbiology and Infectious Diseases 2008 31 2-3 293 315 (Pubitemid 351315120)
78. Sun H., Pollock K. G. J., Brewer J. M., Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro Vaccine 2003 21 9-10 849 855 (Pubitemid 36131100)
79. Clawson C., Huang C. T., Futalan D., Martin Seible D., Saenz R., Larsson M., Ma W., Minev B., Zhang F., Ozkan M., Ozkan C., Esener S., Messmer D., Delivery of a peptide via poly(d,l-lactic- co -glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity Nanomedicine 2010 6 5 651 661
80. Chong C. S. W., Cao M., Wong W. W., Fischer K. P., Addison W. R., Kwon G. S., Tyrrell D. L., Samuel J., Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery Journal of Controlled Release 2005 102 1 85 99 (Pubitemid 40093778)
81. Schll I., Boltz-Nitulescu G., Jensen-Jarolim E., Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy Journal of Controlled Release 2005 104 1 1 27 (Pubitemid 40615232)
82. Schll I., Kopp T., Bohle B., Jensen-Jarolim E., Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy Immunology and Allergy Clinics of North America 2006 26 2 349 364
83. Schll I., Weissenbck A., Frster-Waldl E., Untersmayr E., Walter F., Willheim M., Boltz-Nitulescu G., Scheiner O., Gabor F., Jensen-Jarolim E., Allergen-loaded biodegradable poly(D,L-lactic- co -glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model Clinical and Experimental Allergy 2004 34 2 315 321 (Pubitemid 38315270)
84. Partidos C. D., Vohra P., Jones D. H., Farrar G., Steward M. W., Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles Journal of Controlled Release 1999 62 3 325 332 (Pubitemid 29476580)
85. Batanero E., Barral P., Villalba M., Rodrguez R., Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen Journal of Immunological Methods 2002 259 1-2 87 94 (Pubitemid 33124387)
86. Camacho A. I., Da Costa Martins R., Tamayo I., de Souza J., Lasarte J. J., Mansilla C., Esparza I., Irache J. M., Gamazo C., Poly(methyl vinyl ether- co -maleic anhydride) nanoparticles as innate immune system activators Vaccine 2011 29 41 7130 7135
87. Johansen P., Men Y., Merkle H. P., Gander B., Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 129 146 (Pubitemid 30326693)
88. Mallapragada S. K., Narasimhan B., Immunomodulatory biomaterials International Journal of Pharmaceutics 2008 364 2 265 271
89. Murillo M., Gamazo C., Irache J. M., Goi M. M., Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity Journal of Drug Targeting 2002 10 3 211 219 (Pubitemid 34467290)
90. Hans M. L., Lowman A. M., Biodegradable nanoparticles for drug delivery and targeting Current Opinion in Solid State and Materials Science 2002 6 4 319 327 (Pubitemid 36238389)
91. Vila A., Gill H., McCallion O., Alonso M. J., Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density Journal of Controlled Release 2004 98 2 231 244 (Pubitemid 38950733)
92. Bharali D. J., Pradhan V., Elkin G., Qi W., Hutson A., Mousa S. A., Thanavala Y., Novel nanoparticles for the delivery of recombinant hepatitis B vaccine Nanomedicine 2008 4 4 311 317
93. Vila A., Snchez A., Tobo M., Calvo P., Alonso M. J., Design of biodegradable particles for protein delivery Journal of Controlled Release 2002 78 13 15 24 (Pubitemid 34081849)
94. Vila A., Snchez A., vora C., Soriano I., McCallion O., Alonso M. J., PLA-PEG particles as nasal protein carriers: the influence of the particle size International Journal of Pharmaceutics 2005 292 1-2 43 52 (Pubitemid 40255787)
95. Sinha V. R., Bansal K., Kaushik R., Kumria R., Trehan A., Poly- -caprolactone microspheres and nanospheres: an overview International Journal of Pharmaceutics 2004 278 1 1 23 (Pubitemid 38670433)
96. Jameela S. R., Suma N., Misra A., Raghuvanshi R., Ganga S., Jayakrishnan A., Poly( -caprolactone) microspheres as a vaccine carrier Current Science 1996 70 7 669 671 (Pubitemid 126428206)
97. Florindo H. F., Pandit S., Lacerda L., Gonalves L. M. D., Alpar H. O., Almeida A. J., The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-caprolactone-based nanoparticles Biomaterials 2009 30 5 879 891
98. Arbs P., Arangoa M. A., Campanero M. A., Irache J. M., Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles International Journal of Pharmaceutics 2002 242 1-2 129 136
99. Vandamme K., Melkebeek V., Cox E., Deforce D., Lenoir J., Adriaens E., Vervaet C., Remon J. P., Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination European Journal of Pharmaceutics and Biopharmaceutics 2010 74 2 202 208
100. Arbs P., Campanero M. A., Arangoa M. A., Renedo M. J., Irache J. M., Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties Journal of Controlled Release 2003 89 1 19 30 (Pubitemid 36412111)
101. Salman H. H., Gamazo C., Campanero M. A., Irache J. M., Salmonella-like bioadhesive nanoparticles Journal of Controlled Release 2005 106 1-2 1 13 (Pubitemid 41140076)
102. Yoncheva K., Gmez S., Campanero M. A., Gamazo C., Irache J. M., Bioadhesive properties of pegylated nanoparticles Expert Opinion on Drug Delivery 2005 2 2 205 218 (Pubitemid 41130878)
103. Gmez S., Gamazo C., Roman B. S., Ferrer M., Sanz M. L., Irache J. M., Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens Vaccine 2007 25 29 5263 5271 (Pubitemid 46977542)
104. Gmez S., Gamazo C., San Roman B., Grau A., Espuelas S., Ferrer M., Sanz M. L., Irache J. M., A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne Journal of Immunological Methods 2009 348 1-2 1 8
105. Gmez S., Gamazo C., Roman B. S., Vauthier C., Ferrer M., Irache J. M., Development of a novel vaccine delivery system based on gantrez nanoparticles Journal of Nanoscience and Nanotechnology 2006 6 9-10 3283 3289 (Pubitemid 44580012)
106. Irache J. M., Salman H. H., Gomez S., Espuelas S., Gamazo C., Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination Frontiers in Bioscience 2010 2 876 890
107. Ochoa J., Irache J. M., Tamayo I., Walz A., DelVecchio V. G., Gamazo C., Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice Vaccine 2007 25 22 4410 4419 (Pubitemid 46678567)
108. Tamayo I., Irache J. M., Mansilla C., Ochoa-Repraz J., Lasarte J. J., Gamazo C., Poly(anhydride) nanoparticles act as active Th1 adjuvants through toll-like receptor exploitation Clinical and Vaccine Immunology 2010 17 9 1356 1362
109. Akagi T., Kaneko T., Kida T., Akashi M., Preparation and characterization of biodegradable nanoparticles based on poly( -glutamic acid) with L-phenylalanine as a protein carrier Journal of Controlled Release 2005 108 2-3 226 236 (Pubitemid 41608656)
110. Broos S., Lundberg K., Akagi T., Kadowaki K., Akashi M., Greiff L., Borrebaeck C. A. K., Lindstedt M., Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy Vaccine 2010 28 31 5075 5085
111. Uto T., Akagi T., Yoshinaga K., Toyama M., Akashi M., Baba M., The induction of innate and adaptive immunity by biodegradable poly( -glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway Biomaterials 2011 32 22 5206 5212
112. Zolnik B. S., Gonzlez-Fernndez Á., Sadrieh N., Dobrovolskaia M. A., Minireview: nanoparticles and the immune system Endocrinology 2010 151 2 458 465
113. Lee D. H., Kang I. J., Drug delivery system using biodegradable nanoparticles carrier Kona 2006 24 159 166
114. Jayakumar R., Nwe N., Tokura S., Tamura H., Sulfated chitin and chitosan as novel biomaterials International Journal of Biological Macromolecules 2007 40 3 175 181 (Pubitemid 46215727)
115. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A. N., Davis S. S., Chitosan as a novel nasal delivery system for vaccines Advanced Drug Delivery Reviews 2001 51 13 81 96 (Pubitemid 32763074)
116. Bowman K., Leong K. W., Chitosan nanoparticles for oral drug and gene delivery International Journal of Nanomedicine 2006 1 2 117 128
117. Masotti A., Ortaggi G., Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery Mini-Reviews in Medicinal Chemistry 2009 9 4 463 469
118. Nagpal K., Singh S. K., Mishra D. N., Chitosan nanoparticles: a promising system in novel drug delivery Chemical and Pharmaceutical Bulletin 2010 58 11 1423 1430
119. Van der Lubben I. M., Verhoef J. C., Borchard G., Junginger H. E., Chitosan for mucosal vaccination Advanced Drug Delivery Reviews 2001 52 2 139 144 (Pubitemid 33079169)
120. Borchard G., Chitosans for gene delivery Advanced Drug Delivery Reviews 2001 52 2 145 150 (Pubitemid 33079170)
121. Jiang H. L., Kim Y. K., Arote R., Nah J. W., Cho M. H., Choi Y. J., Akaike T., Cho C. S., Chitosan-graft-polyethylenimine as a gene carrier Journal of Controlled Release 2007 117 2 273 280 (Pubitemid 46161875)
122. Rudzinski W. E., Aminabhavi T. M., Chitosan as a carrier for targeted delivery of small interfering RNA International Journal of Pharmaceutics 2010 399 1-2 1 11
123. Il'ina A. V., Varlamov V. P., Chitosan-based polyelectrolyte complexes: a review Applied Biochemistry and Microbiology 2005 41 1 5 11 (Pubitemid 40363120)
124. Vila A., Snchez A., Janes K., Behrens I., Kissel T., Jato J. L. V., Alonso M. J., Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice European Journal of Pharmaceutics and Biopharmaceutics 2004 57 1 123 131 (Pubitemid 38058811)
125. Roy K., Mao H. Q., Huang S. K., Leong K. W., Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy Nature Medicine 1999 5 4 387 391 (Pubitemid 29180575)
126. Li F., Wang L., Jin X. M., Yan C. H., Jiang S., Shen X. M., The immunologic effect of TGF-beta1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice Immunobiology 2009 214 2 87 99
127. Zhu S., Qian F., Zhang Y., Tang C., Yin C., Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles European Polymer Journal 2007 43 6 2244 2253 (Pubitemid 46856403)
128. Agnihotri S. A., Mallikarjuna N. N., Aminabhavi T. M., Recent advances on chitosan-based micro- and nanoparticles in drug delivery Journal of Controlled Release 2004 100 1 5 28 (Pubitemid 39445982)
129. Domard A., Rinaudo M., Terrassin C., New method for the quaternization of chitosan International Journal of Biological Macromolecules 1986 8 2 105 107 (Pubitemid 16140315)
130. Kotze A. F., Thanou M. M., Luessen H. L., De Boer A. B. G., Verhoef J. C., Junginger H. E., Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2) European Journal of Pharmaceutics and Biopharmaceutics 1999 47 3 269 274 (Pubitemid 29257886)
131. Mangal S., Pawar D., Garg N. K., Jain A. K., Vyas S. P., Rao D. S. V. R., Jaganathan K. S., Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally Vaccine 2011 29 31 4953 4962
132. Borges O., Borchard G., Verhoef J. C., De Sousa A., Junginger H. E., Preparation of coated nanoparticles for a new mucosal vaccine delivery system International Journal of Pharmaceutics 2005 299 1-2 155 166 (Pubitemid 40962417)
133. Borges O., Silva M., de Sousa A., Borchard G., Junginger H. E., Cordeiro-da-Silva A., Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen International Immunopharmacology 2008 8 13-14 1773 1780
134. Borges O., Tavares J., de Sousa A., Borchard G., Junginger H. E., Cordeiro-da-Silva A., Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles European Journal of Pharmaceutical Sciences 2007 32 4-5 278 290 (Pubitemid 350051890)
135. Ho J., Al-Deen F. M. N., Al-Abboodi A., Selomulya C., Xiang S. D., Plebanski M., Forde G. M., N,N'-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier Colloids and Surfaces B 2011 83 1 83 90
136. Fifis T., Gamvrellis A., Crimeen-Irwin B., Pietersz G. A., Li J., Mottram P. L., McKenzie I. F. C., Plebanski M., Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors Journal of Immunology 2004 173 5 3148 3154 (Pubitemid 39142021)
137. Song R., Harding C. V., Roles of proteasomes, transporter for antigen presentation (TAP), and 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway Journal of Immunology 1996 156 11 4182 4190
138. Vidard L., Kovacsovics-Bankowski M., Kraeft S. K., Chen L. B., Benacerraf B., Rock K. L., Analysis of MHC class II presentation of particulate antigens by B lymphocytes Journal of Immunology 1996 156 8 2809 2818 (Pubitemid 126660628)
139. Zhang L., Widera G., Bleecher S., Zaharoff D. A., Mossop B., Rabussay D., Accelerated immune response to DNA vaccines DNA and Cell Biology 2003 22 12 815 822 (Pubitemid 38033004)
140. Mahvi D. M., Shi F. S., Yang N. S., Weber S., Hank J., Albertini M., Schiller J., Schalch H., Larson M., Pharo L., Gan J., Heisey D., Warner T., Sondel P. M., Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study Human Gene Therapy 2002 13 14 1711 1721 (Pubitemid 35191746)
141. Parween S., Gupta P. K., Chauhan V. S., Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum Vaccine 2011 29 13 2451 2460
142. Kwon Y. J., Standley S. M., Goh S. L., Fréchet J. M. J., Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles Journal of Controlled Release 2005 105 3 199 212 (Pubitemid 40941986)
143. Kwon Y. J., James E., Shastri N., Fréchet J. M. J., In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles Proceedings of the National Academy of Sciences of the United States of America 2005 102 51 18264 18268 (Pubitemid 43011215)